Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia
ACTIVE_NOT_RECRUITING
Status
Conditions
- Chronic Lymphocytic Leukemia
- Recurrent Chronic Lymphocytic Leukemia
- Recurrent Small Lymphocytic Lymphoma
- Refractory Chronic Lymphocytic Leukemia
- Refractory Small Lymphocytic Lymphoma
- Small Lymphocytic Lymphoma
Interventions
- DRUG: Ibrutinib
- OTHER: Laboratory Biomarker Analysis
- DRUG: Venetoclax
Sponsor
M.D. Anderson Cancer Center